BD Diagnostics announced that it has received clearance from the FDA for nasopharyngeal wash, aspirate, and swab in transport media specimens on the BD Veritor System for Rapid Detection of respiratory syncytial virus (RSV).

The BD Veritor System eliminates the subjective result interpretation of visually read assays and helps deliver an accurate read by providing reliable, objective results on a hand held reader with an easy-to-read digital display.  The system utilizes Advanced Particle and Adaptive Read Technologies coupled with a special hand-held analyzer.  The Advanced Particle Technology helps improve the sensitivity of the test while the Adaptive Read Technology helps reduce false-positive results by examining and compensating for many of the effects of non-specific binding which improves specificity. 

The BD Veritor System is currently cleared for use in clinical settings.

For more information call (800) 675-0908 or visit